These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 5339067)
41. [Hemorrhagic complications of fibrinolysis]. SAMAMA M; YVER J; WEISS M Vie Med; 1962 Jun; 43(Special)():51-5 passim. PubMed ID: 14496564 [No Abstract] [Full Text] [Related]
42. CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS. ENDE N; AUDITORE JV Ann Surg; 1963 Jul; 158(1):117-25. PubMed ID: 14042622 [No Abstract] [Full Text] [Related]
43. [The effect of Werlhof's disease in the mother on the state and development of the newborn]. Sautina VO; Elizarova IP Vopr Okhr Materin Det; 1968 Jan; 13(1):38-41. PubMed ID: 5752813 [No Abstract] [Full Text] [Related]
44. [Hypofibrinogenemia and fibrinolysis in metastatic cancer of the prostate as a rare cause of unilateral renal hemorrhage]. STEFAN H; CHROBAK L; GROH J Cas Lek Cesk; 1960 Mar; 99():302-6. PubMed ID: 13833992 [No Abstract] [Full Text] [Related]
45. [FIBRINOLYSIS; APPLICATION IN THE CLINIC (EPSILON-AMINOCAPROIC ACID)]. MOERS AM; BOSMAN GA Folia Med Neerl; 1964 Dec; 7():175-8. PubMed ID: 14265805 [No Abstract] [Full Text] [Related]
46. Bleeding disorders associated with cancer dysproteinemias. Zangari M; Elice F; Tricot G; Fink L Cancer Treat Res; 2009; 148():295-304. PubMed ID: 19377931 [No Abstract] [Full Text] [Related]
47. [DETECTION AND INCIDENCE OF FIBRINOLYSIS IN THE MEDICAL, OBSTETRICAL AND SURGICAL FIELDS. COMPARISON OF METHODS OF DETECTION]. CROIZAT P; FAVRE-GILLY L Sangre (Barc); 1964; 61():57-60. PubMed ID: 14214886 [No Abstract] [Full Text] [Related]
48. [INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. I. SPECIFIC INHIBITORS OF FIBRINOLYSIS]. NIEWIAROWSKI S Pol Arch Med Wewn; 1964; 34():211-7. PubMed ID: 14151493 [No Abstract] [Full Text] [Related]
49. [Disorders of coagulation/fibrinolysis and bleeding tendency]. Endo T; Amemiya N; Kume S Nihon Rinsho; 1994 Jan; 52(1):119-23. PubMed ID: 8114280 [TBL] [Abstract][Full Text] [Related]
50. [Fibrinolysis as a cause of hemorrhagic diathesis]. ASTRUP T; ALBRECHTSEN OK Ugeskr Laeger; 1956 Apr; 118(15):403-8. PubMed ID: 13352470 [No Abstract] [Full Text] [Related]
51. [USE OF EPSILON-AMINOCAPROIC ACID (EACA) IN GYNECOLOGY AND OBSTETRICS]. BAR PRATKOWSKA J; NIEWIAROWSKA M; DOBRACZYNSKA J Ginekol Pol; 1964; 35():81-6. PubMed ID: 14126161 [No Abstract] [Full Text] [Related]
52. Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia. Gralnick HR; Bagley J; Abrell E Am J Med; 1972 Feb; 52(2):167-74. PubMed ID: 4500954 [No Abstract] [Full Text] [Related]
53. [Fibrinolytic activity of brain tumors and treatment of hemorrhagic diathesis]. Kraus H Schweiz Arch Neurol Neurochir Psychiatr; 1971; 108(1):27-31. PubMed ID: 4256314 [No Abstract] [Full Text] [Related]
54. [Bleeding tendency in newborn infants born of mothers with chronic idiopathic thrombocytopenia]. Nolis J; RobaczyĆska G; Rudkowski Z Pediatr Pol; 1972; 47(5):621-6. PubMed ID: 5028806 [No Abstract] [Full Text] [Related]
55. [Therapy of hemorrhagic diathesis]. Voss D Minerva Med; 1972 Feb; 63(14):834-6. PubMed ID: 4536834 [No Abstract] [Full Text] [Related]
56. Women and inherited bleeding disorders: pregnancy and delivery. Kadir RA Semin Hematol; 1999 Jul; 36(3 Suppl 4):28-35. PubMed ID: 10513769 [TBL] [Abstract][Full Text] [Related]
57. Manifestation and management of hypofibrinogenemia and firinolysis in patients with carcinoma of the prostate. Pellman CM; Ridlon HC; Phillips LL J Urol; 1966 Sep; 96(3):375-9. PubMed ID: 5917494 [No Abstract] [Full Text] [Related]